Epigenetic Markers May be Used to Estimate Anal Cancer Risk

News   May 31, 2017 | Original story from Queen Mary University London

 
Epigenetic Markers May be Used to Estimate Anal Cancer Risk

Microscope image of abnormal cells within the anus. Credit: QMUL

 
 
 
 

RELATED ARTICLES

Are Stem Cells the Link Between Bacteria and Cancer?

News

New mechanism of stomach gland regeneration reveals impact of Helicobacter pylori infection.

READ MORE

New Test Can Distinguish Lyme Disease From STARI

News

Lyme disease is commonly confused with similar conditions such as STARI. A new mass spec based test can identify biomarkers of metabolic differences in the two diseases.

READ MORE

Biofortuna Raises £1.6 Million in Funding Round

News

Biofortuna Ltd has raised £1.6 million, allowing the company to take its blood group genotyping assays into clinical trails and commercialisation.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Diagnostics Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE